Genome&Company — Investor Relations & Filings
Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2024-09-06 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2024-09-06 | Korean | |
| 반기보고서 (2024.06) | 2024-08-14 | Korean | |
| 전환가액의조정 | 2024-08-08 | Korean | |
| 전환가액의조정 | 2024-08-08 | Korean | |
| 권리락 (무상증자) | 2024-08-05 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 8079677 | 주식등의대량보유상황보고서(일반) | 2024-09-06 | Korean | ||
| 8079669 | 주식등의대량보유상황보고서(일반) | 2024-09-06 | Korean | ||
| 8093984 | 반기보고서 (2024.06) | 2024-08-14 | Korean | ||
| 8099395 | 전환가액의조정 | 2024-08-08 | Korean | ||
| 8099368 | 전환가액의조정 | 2024-08-08 | Korean | ||
| 8101444 | 권리락 (무상증자) | 2024-08-05 | Korean | ||
| 8101918 | 주식등의대량보유상황보고서(일반) | 2024-08-02 | Korean | ||
| 8107245 | 주권매매거래정지 (무상증자) | 2024-07-22 | Korean | ||
| 8107243 | 주요사항보고서(무상증자결정) | 2024-07-22 | Korean | ||
| 8107461 | 증권발행결과(자율공시) | 2024-07-19 | Korean | ||
| 8107911 | 기업설명회(IR)개최 | 2024-07-18 | Korean | ||
| 8108406 | 주요사항보고서(전환사채권발행결정) | 2024-07-17 | Korean | ||
| 8114678 | 기업설명회(IR)개최 | 2024-07-01 | Korean | ||
| 8114901 | 기타시장안내 (업종변경 안내) | 2024-06-28 | Korean | ||
| 8119176 | [기재정정]투자판단관련주요경영사항 (GENA-111 기반 항체-약물접합체ADC 개발 및 상업화 기술이전 계약 체결) | 2024-06-26 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Genome&Company via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16628/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16628 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16628 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16628 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16628}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Genome&Company (id: 16628)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.